MAUNA KEA TECH news, videos and press releases
For more news please use our advanced search feature.
MAUNA KEA TECH - More news...
MAUNA KEA TECH - More news...
- Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital
- Mauna Kea Technologies Announces Entrance Into Exclusive Negotiations for a Licensing Agreement for Cellvizio® in an Important Therapeutic Area With a Major Industry Player
- Mauna Kea Technologies Announces the Opening of a Safeguard Proceeding to Restructure Its Financial Liabilities
- Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital
- Mauna Kea Technologies: Cellvizio® Now Recommended in New European Society of Gastrointestinal Endoscopy Technical Guideline for Pancreatic Cyst Diagnosis
- Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital
- Mauna Kea Technologies Announces Promising Results in New Application Combining Robotics and Cellvizio® for Precision Surgery in Head and Neck Cancers
- Mauna Kea Technologies: Half-Year Liquidity Contract Statement for H2 2024 With the Brokerage Firm Gilbert Dupont
- Mauna Kea Technologies Secures Additional U.S. Artificial Intelligence Patent to Strengthen Endomicroscopy IP Complex
- Mauna Kea Technologies Reports Full Year 2024 Sales and Provides Strategic Update
- Mauna Kea Technologies Announces Its 2025 Financial Calendar
- Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital
- Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital
- Mauna Kea Technologies: Raising Pancreatic Cancer Awareness Through Patient Voices
- Mauna Kea Technologies Celebrates Over 700 Procedures Performed in 18 Months at IECED-OMNI Hospital in Ecuador
- Mauna Kea Announces Review of Strategic Alternatives
- Mauna Kea Technologies Provides an Update on Its Recent Developments
- Mauna Kea Technologies Announces the Transfer of its Shares on the Euronext Growth Paris Market Will Be Effective August 8, 2023
- Mauna Kea Technologies: Monthly information regarding the total number of voting rights and shares comprising the share capital
- Mauna Kea Technologies Reports Second Quarter and First Half 2023 Revenue
- Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital
- Mauna Kea Technologies Announces the Installation of Cellvizio® at University College Cork - APC Microbiome Ireland for Inflammatory Bowel Disease (IBD) Applications
- Mauna Kea Technologies: Release of the 2022 Universal Registration Document
- Mauna Kea Technologies Announces the Appointment of Côme de La Tour du Pin as its Chief Financial Officer
- Mauna Kea Technologies Announces the Launch of the Transfer of its Shares to Euronext Growth Paris
- Mauna Kea Technologies Announces Results of its 2023 Ordinary and Extraordinary Annual General Meeting
- Mauna Kea Technologies Announces Start of Enrollment in Peripheral Lung Cancer Multi-Site Clinical Trial Combining Ion® with Cellvizio®
- Mauna Kea Technologies Secures an Equity Line Financing With Vester Finance Limited to a Maximum of 11.4% of the Capital
- Proposed Transfer of the Listing of Mauna Kea Technologies’ Shares to the Euronext Growth Paris Market
- Mauna Kea Technologies Announces Sales of €4.2 million for the first quarter of 2023, up 121% from 2022
